Content about Sweden

March 10, 2014

Aerocrine AB, a medical products company focused on improved management and care of patients with such inflammatory airway diseases as asthma, has announced that a new randomized clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment.

SOLNA, Sweden — Aerocrine AB, a medical products company focused on improved management and care of patients with such inflammatory airway diseases as asthma, has announced that a new randomized clinical trial shows lower incidence of asthma exacerbations and increased asthma control with Fractional exhaled Nitric Oxide (FeNO)-guided anti-inflammatory treatment.  

The study has been published on theweb site of the Journal of Allergy and Clinical Immunology: In Practice.

January 23, 2014

High-fluoride toothpaste may help prevent white spots from braces, according to a Reuters report citing a new study from Sweden.

NEW YORK — High-fluoride toothpaste may help prevent white spots from braces, according to a Reuters report citing a new study from Sweden.

Researchers found that high-fluoride toothpaste, which has nearly four times the amount of fluoride, helped prevent white spots on the teeth of children between the ages of 11 and 16 years old, Reuters reported.

December 19, 2013

Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for treating dental erosion.

GÖTEBORG, Sweden — Meda has signed an agreement to acquire ZpearPoint AS, including global rights to its main product, EB24, an OTC line for  treating dental erosion.  

The EB24 product is based on hydrogen fluoride highly diluted in water. In studies, the product has shown that it is able to penetrate enamel surfaces and form calcium fluoride resulting in an anti-erosive effect. As such, EB24 works as a protective agent against dental erosion. 

September 25, 2013

As part of the Black Chill product launch, Unilever’s Axe is whisking away nine winners — and their friends — to the ultimate winter adventure, the Axe Black Chill Challenge.

ENGLEWOOD CLIFFS, N.J. — As part of the Black Chill product launch, Unilever’s Axe is whisking away nine winners — and their friends — to the ultimate winter adventure, the Axe Black Chill Challenge.

In March of 2014, selected winners will head to Sweden to take part in a series of extreme winter-themed sport activities, such as husky sleigh safaris, snowmobile expeditions through the Alpine Tundra and combat-copter flights overlooking Sweden's Archipelago, to see if they have what it takes to keep their cool in the most intense of situations.

September 4, 2013

IRI announced it has acquired Aztec, a provider of market measurement and related services for consumer packaged goods, liquor and pharmaceutical manufacturers and retailers in Australia, Canada, Hong Kong, New Zealand, South Africa, Sweden and the United Kingdom. Aztec was acquired from Aegis Media.

CHICAGO  — IRI announced it has acquired Aztec, a provider of market measurement and related services for consumer packaged goods, liquor and pharmaceutical manufacturers and retailers in Australia, Canada, Hong Kong, New Zealand, South Africa, Sweden and the United Kingdom. Aztec was acquired from Aegis Media.

August 12, 2013

Moberg Pharma AB announced its U.S. launch of Kerasal NeuroCream, an over-the-counter pain relieving foot cream.

STOCKHOLM, Sweden — Moberg Pharma AB today announced its U.S. launch of Kerasal NeuroCream, an over-the-counter pain relieving foot cream. This new product will be sold in over 3,800 Walmart stores and in CVS, Walgreens, and Rite Aid drug stores starting late August.

December 27, 2012

Researchers at the University of Gothenburg along with the Chalmers University of Technology earlier this month demonstrated that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke.

GOTHENBURG, Sweden — Researchers at the University of Gothenburg along with the Chalmers University of Technology earlier this month demonstrated that an altered gut microbiota in humans is associated with symptomatic atherosclerosis and stroke. 

These findings were presented in a study published in Nature Communications on Dec. 4.

December 7, 2012

Meda announced Friday that it has signed an agreement to acquire MidNite, an OTC sleep-aid product.

SOLNA, Sweden — Meda announced Friday that it has signed an agreement to acquire MidNite, an OTC sleep-aid product. MidNite is well established in the U.S. and holds a market leading position within a growing category. Transaction terms were not disclosed.

“This acquisition enhances our presence in the U.S. ahead of other future OTC launches," stated Anders Lönner, CEO of Meda. 

Annualized revenues for MidNite are approximately $15 million, the company reported. 

March 1, 2011

Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

HUDDINGE, Sweden — Meda has launched a new cold sore treatment made by commercialization partner Medivir, Medivir said Tuesday.

The Swedish drug maker launched Xerese (acyclovir and hydrocortisone), a topical combination product designed to treat recurrent herpes simplex labialis.

Medivir said the U.S. market for cold sore products is $230 million, and it expected the drug to be successful, given Meda’s presence in the U.S. market.

January 10, 2011

Boots Pharmaceutical Enterprises, the partnership between the U.K. pharmacy chain Boots and local operator Pharmaceutical Enterprises, in the next two months is expected to open the first of 100 pharmacies across Sweden, according to a report in The Local, an English-language Swedish newspaper.

STOCKHOLM, Sweden — Boots Pharmaceutical Enterprises, the partnership between the U.K. pharmacy chain Boots and local operator Pharmaceutical Enterprises, in the next two months is expected to open the first of 100 pharmacies across Sweden, according to a report in The Local, an English-language Swedish newspaper.

”We are busy recruiting candidates and finding premises here in Sweden,” Sverker Littorin, Pharmaceutical Enterprises chairman told the newspaper. “Everything is on track, even though it is several months later than we had hoped.”

September 19, 2010

An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar...

PARIS An injected insulin made by French drug maker Sanofi-Aventis provided further reduction of blood sugar in patients with Type 2 diabetes when added to oral diabetes drugs, according to a study presented at a medical conference in Sweden.